Literature DB >> 3791697

The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

D A Campbell, R M du Bois, R G Butcher, L W Poulter.   

Abstract

The density of HLA-DR antigen expression on alveolar macrophages obtained by bronchoalveolar lavage from sarcoidosis patients and normal control subjects was quantified using scanning and integrating microdensitometry in conjunction with a monoclonal mouse anti-human HLA-DR antibody directly conjugated to fungal glucose oxidase. The density of HLA-DR antigen expression on alveolar macrophages was significantly increased in the pulmonary sarcoidosis patients compared with normal control subjects examined. The reproducibility, specificity and sensitivity establish the reliability and potential importance of this method of direct quantification of cell surface antigen expression. The demonstration of an increased density of Class II Major Histocompatibility Complex (MHC) antigen expression on alveolar macrophages in pulmonary sarcoidosis suggests that these cells may play a role in the induction of the immune responses at sites of disease activity in this poorly understood condition.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791697      PMCID: PMC1542278     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

Review 1.  The alveolar macrophage.

Authors:  R M du Bois
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

Review 2.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

3.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

Review 4.  Antigen presenting cells in situ: their identification and involvement in immunopathology.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

5.  Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.

Authors:  P L Haslam; C W Turton; B Heard; A Lukoszek; J V Collins; A J Salsbury; M Turner-Warwick
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

6.  Expression of Ia-like (DR) antigen on human alveolar macrophages isolated by bronchoalveolar lavage.

Authors:  A G Razma; J P Lynch; B S Wilson; P A Ward; S L Kunkel
Journal:  Am Rev Respir Dis       Date:  1984-03

7.  Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1984-04

8.  Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.

Authors:  A Venet; A J Hance; C Saltini; B W Robinson; R G Crystal
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

9.  Interferon regulation of DR antigen expression and alloantigen-presenting capabilities of the promyelocytic cell line HL60.

Authors:  P S Steeg; M B Sztein; D L Mann; D M Strong; J J Oppenheim
Journal:  Scand J Immunol       Date:  1985-05       Impact factor: 3.487

Review 10.  Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

Authors:  R P Daniele; J A Elias; P E Epstein; M D Rossman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

View more
  14 in total

1.  Reduction in HLA-DR antigen density on alveolar macrophages of smokers.

Authors:  W Pankow; K Neumann; J Rüschoff; R Schröder; P von Wichert
Journal:  Lung       Date:  1991       Impact factor: 2.584

2.  Normal and sarcoid alveolar macrophages differ in their ability to present antigen and to cluster with autologous lymphocytes.

Authors:  V A Gant; Z Shakoor; I L Barbosa; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 3.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

4.  Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis.

Authors:  M A Spiteri; S W Clarke; L W Poulter
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  T-cell cytokines may control the balance of functionally distinct macrophage populations.

Authors:  V J Tormey; J Faul; C Leonard; C M Burke; A Dilmec; L W Poulter
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

6.  The immunological component of the cellular inflammatory infiltrate in bronchiectasis.

Authors:  J R Silva; J A Jones; P J Cole; L W Poulter
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

7.  Enrichment and characterization of dendritic cells from human bronchoalveolar lavages.

Authors:  C E Havenith; J M van Haarst; A J Breedijk; M G Betjes; H C Hoogsteden; R H Beelen; E C Hoefsmit
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

8.  Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.

Authors:  M Gaga; A M Bentley; M Humbert; J Barkans; F O'Brien; C G Wathen; A B Kay; S R Durham
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

9.  Correlation of morphological patterns of nucleoli in alveolar macrophages with HLA-DR antigen expression in sarcoidosis.

Authors:  W Popp; F J Wachtler
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

10.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.